Applied Therapeutics Inc (APLT)

$0.10 +0.01 (7.64%)
Market Cap 14.36M
Revenue (ttm) 460,000.00
Net Income (ttm) -105.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -22,960.87%
Debt to Equity Ratio 0.00
Volume 4,231,200
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 153.96M
Stochastic %K N/A
Beta 2.08
Analysts Hold
Price Target $0.25

Company Profile

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, an...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 220 9226
Address:
545 Fifth Avenue, Suite 1400, New York, United States
11thestate
11thestate May. 11 at 2:48 PM
If you missed the deadline, don’t miss this update. You may still be able to recover losses from $APLT; late claims are currently being accepted: https://11th.com/cases/applied-therapeutics-investor-suit This recovery fund was established after claims that Applied Therapeutics misled investors about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review. Even though the official deadline has passed, the court is still accepting late submissions. Who can apply? If you bought or held $APLT between January 3, 2024, and December 2, 2024, you’re likely eligible even if you already sold your shares.
0 · Reply
11thestate
11thestate May. 7 at 1:57 PM
If you missed the deadline, don’t miss this update. You may still be able to recover losses from $APLT, late claims are currently being accepted: https://11th.com/cases/applied-therapeutics-investor-suit This recovery fund was established after claims that Applied Therapeutics misled them about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review.Even though the official deadline has passed, the court is still accepting late submissions. Who can apply? If you bought or held $APLT between January 3, 2024, and December 2, 2024,, you’re likely eligible even if you already sold your shares.
0 · Reply
11thestate
11thestate Apr. 28 at 4:43 PM
Missed the Applied Therapeutics ($APLT) deadline? You can still file Most investors assume they're out of luck once the date passes, but the $15 million Applied Therapeutics settlement is currently accepting "Late-but-Valid" claims. If you bought shares between January 3, 2024, and December 2, 2024, you still have a chance to seek recovery. Check the details and submit your late claim here: https://11th.com/cases/applied-therapeutics-investor-suit What is this settlement about? This recovery fund was established after claims that Applied Therapeutics misled investors about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review. Even though the official deadline has passed, the court is still accepting late submissions.
0 · Reply
CAMDENBEER
CAMDENBEER Apr. 23 at 11:55 AM
$APLT how's that CVR from APLT working out for you LOSERS? worthless and collecting dust.??? you all bought a scam! Please admit. I was right about everything!
0 · Reply
11thestate
11thestate Apr. 3 at 1:30 PM
$APLT deadline is next week and most investors still haven't filed. Applied Therapeutics reached a $15M settlement after being accused of hiding trial deficiencies and misleading investors about FDA readiness. The stock dropped 80% when the truth came out in late 2024. If you were invested between Jan 2024 and Dec 2024, April 8 is your last chance. Check if you qualify 👉 https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
11thestate
11thestate Mar. 31 at 2:10 PM
$APLT has agreed to settle with investors over claims that it misled them about its lead drug candidate by hiding dosing errors and missing trial data, which led to a failed FDA review. Who’s eligible? Anyone who purchased $APLT shares between January 3, 2024 and December 2, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.48 — but normally only ~25% of eligible investors file, the effective payout could increase to $1.92. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
11thestate
11thestate Mar. 30 at 2:57 PM
$APLT has reached a $15M settlement with $APLT investors over claims that it misled them about its lead drug candidate by hiding dosing errors and missing trial data. The filing deadline is April 8, 2026. If you bought $APLT between January 3, 2024 and December 2, 2024, you can file for payment here: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
Mhsahi1539
Mhsahi1539 Mar. 25 at 3:12 PM
$APLT can some body explain what does CVR mean and should i consider all of money is dumped?
0 · Reply
11thestate
11thestate Mar. 25 at 1:52 PM
A common question: what about legal fees? Here's how it works: attorney fees in $APLT $15,000,000 settlement are approved separately by the court — and are capped by law. They don't come out of your payout. The fund set aside for investors is exactly that — for investors. If you bought between January 3, 2024, and December 2, 2024, what's waiting for you has nothing to do with what the lawyers earn. Check your eligibility here: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
11thestate
11thestate Mar. 24 at 3:58 PM
This settlement has no impact on $APLT's stock price. Applied Therapeutics already reached a $15M agreement with investors. The case is closed. The settlement fund doesn't come from current operations — it comes from a legal process that has already concluded. You can still be a shareholder and file a claim at the same time. They're not mutually exclusive. If you bought between January 3, 2024 and December 2, 2024, check if you qualify: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
Latest News on APLT
Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics

Feb 3, 2026, 8:39 AM EST - 3 months ago

Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics

Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer

Jan 30, 2026, 8:00 AM EST - 3 months ago

Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer

Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension

Jan 29, 2026, 8:15 AM EST - 3 months ago

Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension

Cycle Pharmaceuticals to Acquire Applied Therapeutics

Dec 11, 2025, 5:25 PM EST - 5 months ago

Cycle Pharmaceuticals to Acquire Applied Therapeutics

Applied Therapeutics Announces Corporate Updates

Nov 20, 2025, 7:00 AM EST - 6 months ago

Applied Therapeutics Announces Corporate Updates

Applied Therapeutics Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 7:00 AM EST - 6 months ago

Applied Therapeutics Reports Third Quarter 2025 Financial Results

Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 28, 2025, 10:25 AM EDT - 7 months ago

Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Applied Therapeutics Provides Update Following Meeting with FDA

Sep 29, 2025, 7:00 AM EDT - 8 months ago

Applied Therapeutics Provides Update Following Meeting with FDA

Applied Therapeutics Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 5:11 PM EDT - 9 months ago

Applied Therapeutics Reports Second Quarter 2025 Financial Results

Applied Therapeutics Announces Key Leadership Appointments

Jun 17, 2025, 4:05 PM EDT - 11 months ago

Applied Therapeutics Announces Key Leadership Appointments

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

May 18, 2025, 7:28 AM EDT - 1 year ago

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Reports First Quarter 2025 Financial Results

May 13, 2025, 5:00 PM EDT - 1 year ago

Applied Therapeutics Reports First Quarter 2025 Financial Results

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

May 9, 2025, 5:00 PM EDT - 1 year ago

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

Mar 31, 2025, 7:10 AM EDT - 1 year ago

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

Mar 19, 2025, 7:00 AM EDT - 1 year ago

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT)

Feb 16, 2025, 7:18 AM EST - 1 year ago

APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT)

APLT SHAREHOLDER NEWS: Applied Therapeutics Investors that Lost Money may have been affected by Fraud - Contact BFA Law by February 18 Deadline

Feb 12, 2025, 3:18 PM EST - 1 year ago

APLT SHAREHOLDER NEWS: Applied Therapeutics Investors that Lost Money may have been affected by Fraud - Contact BFA Law by February 18 Deadline

11thestate
11thestate May. 11 at 2:48 PM
If you missed the deadline, don’t miss this update. You may still be able to recover losses from $APLT; late claims are currently being accepted: https://11th.com/cases/applied-therapeutics-investor-suit This recovery fund was established after claims that Applied Therapeutics misled investors about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review. Even though the official deadline has passed, the court is still accepting late submissions. Who can apply? If you bought or held $APLT between January 3, 2024, and December 2, 2024, you’re likely eligible even if you already sold your shares.
0 · Reply
11thestate
11thestate May. 7 at 1:57 PM
If you missed the deadline, don’t miss this update. You may still be able to recover losses from $APLT, late claims are currently being accepted: https://11th.com/cases/applied-therapeutics-investor-suit This recovery fund was established after claims that Applied Therapeutics misled them about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review.Even though the official deadline has passed, the court is still accepting late submissions. Who can apply? If you bought or held $APLT between January 3, 2024, and December 2, 2024,, you’re likely eligible even if you already sold your shares.
0 · Reply
11thestate
11thestate Apr. 28 at 4:43 PM
Missed the Applied Therapeutics ($APLT) deadline? You can still file Most investors assume they're out of luck once the date passes, but the $15 million Applied Therapeutics settlement is currently accepting "Late-but-Valid" claims. If you bought shares between January 3, 2024, and December 2, 2024, you still have a chance to seek recovery. Check the details and submit your late claim here: https://11th.com/cases/applied-therapeutics-investor-suit What is this settlement about? This recovery fund was established after claims that Applied Therapeutics misled investors about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review. Even though the official deadline has passed, the court is still accepting late submissions.
0 · Reply
CAMDENBEER
CAMDENBEER Apr. 23 at 11:55 AM
$APLT how's that CVR from APLT working out for you LOSERS? worthless and collecting dust.??? you all bought a scam! Please admit. I was right about everything!
0 · Reply
11thestate
11thestate Apr. 3 at 1:30 PM
$APLT deadline is next week and most investors still haven't filed. Applied Therapeutics reached a $15M settlement after being accused of hiding trial deficiencies and misleading investors about FDA readiness. The stock dropped 80% when the truth came out in late 2024. If you were invested between Jan 2024 and Dec 2024, April 8 is your last chance. Check if you qualify 👉 https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
11thestate
11thestate Mar. 31 at 2:10 PM
$APLT has agreed to settle with investors over claims that it misled them about its lead drug candidate by hiding dosing errors and missing trial data, which led to a failed FDA review. Who’s eligible? Anyone who purchased $APLT shares between January 3, 2024 and December 2, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.48 — but normally only ~25% of eligible investors file, the effective payout could increase to $1.92. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
11thestate
11thestate Mar. 30 at 2:57 PM
$APLT has reached a $15M settlement with $APLT investors over claims that it misled them about its lead drug candidate by hiding dosing errors and missing trial data. The filing deadline is April 8, 2026. If you bought $APLT between January 3, 2024 and December 2, 2024, you can file for payment here: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
Mhsahi1539
Mhsahi1539 Mar. 25 at 3:12 PM
$APLT can some body explain what does CVR mean and should i consider all of money is dumped?
0 · Reply
11thestate
11thestate Mar. 25 at 1:52 PM
A common question: what about legal fees? Here's how it works: attorney fees in $APLT $15,000,000 settlement are approved separately by the court — and are capped by law. They don't come out of your payout. The fund set aside for investors is exactly that — for investors. If you bought between January 3, 2024, and December 2, 2024, what's waiting for you has nothing to do with what the lawyers earn. Check your eligibility here: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
11thestate
11thestate Mar. 24 at 3:58 PM
This settlement has no impact on $APLT's stock price. Applied Therapeutics already reached a $15M agreement with investors. The case is closed. The settlement fund doesn't come from current operations — it comes from a legal process that has already concluded. You can still be a shareholder and file a claim at the same time. They're not mutually exclusive. If you bought between January 3, 2024 and December 2, 2024, check if you qualify: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
11thestate
11thestate Mar. 23 at 3:03 PM
The estimated payout for $APLT is $0.48 per share. But historically, only 25% of eligible investors actually file a claim — which means the fund gets split among fewer people, and the real payout could reach $1.92 per share. If you bought between January 3, 2024 and December 2, 2024, the process takes less than 5 minutes. You decide if it's worth it: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
11thestate
11thestate Mar. 19 at 2:21 PM
With everything going on around $APLT lately — this is the info you don't want to miss: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
CAMDENBEER
CAMDENBEER Mar. 18 at 2:38 PM
$APLT how's that CVR working out for you bagholders? worthless and collecting dust. you all bought a scam!
0 · Reply
11thestate
11thestate Mar. 12 at 2:48 PM
$APLT investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
AndyHazy
AndyHazy Mar. 10 at 4:36 PM
$APLT Anyone else received a dividend payment today from APLT?
1 · Reply
11thestate
11thestate Mar. 10 at 2:34 PM
$APLT has agreed to settle with investors over claims that it misled them about clinical trial data and regulatory readiness for its lead drug Govorestat. Who's eligible? Anyone who purchased $APLT shares between January 3, 2024 and December 2, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.48 — but normally only ~25% of eligible investors file, the effective payout could increase to $1.92. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
11thestate
11thestate Mar. 3 at 1:27 PM
$APLT investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
11thestate
11thestate Feb. 23 at 2:27 PM
Did you know? Only around 25% of eligible investors usually file in settlements like $APLT ’s $15M payout. Stat: If that happens here, the estimated $0.48 per share could possibly increase to about $1.92 per share, depending on how many investors actually file valid claims. Fact: If you bought between January 3, 2024 and December 2, 2024, you may be eligible to submit a claim before April 8, 2026: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
StockBraker
StockBraker Feb. 22 at 8:23 PM
$APLT REMINDER - https://www.apltsecuritiessettlement.com/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 21 at 11:13 PM
$APLT RSI: 54.57, MACD: -0.0198 Vol: 0.00, MA20: 0.10, MA50: 0.14 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
11thestate
11thestate Feb. 20 at 12:21 PM
$APLT has reached a $15M settlement with $APLT investors over claims that it misled them about its lead drug candidate by hiding dosing errors and missing trial data, which ultimately led to a failed FDA review. The filing deadline is April 8, 2026. If you bought $APLT between January 3, 2024 and December 2, 2024, you can file for payment here: https://11th.com/cases/applied-therapeutics-investor-suit
0 · Reply
dpickles
dpickles Feb. 17 at 3:51 PM
$SGMO $0 soon I guess like $APLT fuck us all right as long as sandy and co get paid
1 · Reply